Fortrea Holdings Inc.
Fortrea Holdings Inc. operates as a leading provider of clinical research services and solutions to the pharmaceutical, biotechnology, and medical device industries. The company, which trades on the Nasdaq under ticker symbol FRTA, maintains its corporate presence at www.fortrea.com. From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Fortrea Holdings Inc. does
In the company’s own words
Fortrea Holdings Inc. operates as a leading provider of clinical research services and solutions to the pharmaceutical, biotechnology, and medical device industries. The company, which trades on the Nasdaq under ticker symbol FRTA, maintains its corporate presence at www.fortrea.com.
The company delivers comprehensive clinical trial services spanning Phase I through Phase IV studies, encompassing patient recruitment, site management, data collection, and regulatory compliance support. Fortrea's service offerings extend across therapeutic areas including oncology, cardiovascular, neurology, immunology, and rare diseases, serving as a critical infrastructure partner for sponsors conducting clinical development programs globally.
Fortrea operates through integrated business segments that provide end-to-end clinical research capabilities. The company maintains an extensive network of clinical research sites and service centers positioned to support multi-site trial execution across North America, Europe, and other international markets. The organization employs thousands of clinical research professionals, including principal investigators, coordinators, and support staff distributed across numerous facilities.
The company's business model centers on providing specialized expertise and operational infrastructure that enables pharmaceutical and biotech companies to accelerate clinical development timelines while managing regulatory requirements and ensuring patient safety. Fortrea generates revenue through service fees based on trial complexity, patient enrollment volumes, and the scope of site management and data services provided.
Fortrea's competitive positioning derives from its established relationships with leading pharmaceutical sponsors, deep expertise in regulatory requirements across multiple jurisdictions, and operational scale enabling efficient multi-site trial management. The company maintains proprietary technology platforms supporting electronic data capture, patient management, and trial analytics that enhance operational efficiency and data quality.
The organization's history reflects the consolidation and evolution of clinical research services, with the company having developed through strategic combinations that expanded its geographic footprint and therapeutic expertise. This foundation enables Fortrea to serve as a comprehensive partner for sponsors navigating increasingly complex clinical development landscapes while maintaining focus on operational excellence and regulatory compliance standards essential to the clinical research industry.
Company details
- Sector
- Health Care
- Industry (SIC)
- Health Services
- Headquarters
- DURHAM, NC
- Fiscal year end
- December
- CIK
- 1965040
- SIC
- 8071
Financial performance, year by year
Fiscal 2023–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Fortrea Holdings Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Fortrea Holdings Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fortrea Holdings Inc.’s bonds, as funds hold them
Funds report holding 1 issues of Fortrea Holdings Inc.’s debt, $145.93M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 7.50%, maturing 2030 to 2030.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Fortrea Holdings Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Fortrea Holdings Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Fortrea Holdings Inc.'s last four quarterly filings that the numbers alone won't show?”